4//SEC Filing
Akinsanya Karen 4
Accession 0001490978-25-000021
CIK 0001490978other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:29 PM ET
Size
7.4 KB
Accession
0001490978-25-000021
Insider Transaction Report
Form 4
Akinsanya Karen
President of R&D, Therapeutics
Transactions
- Award
Common Stock
2025-03-03+15,625→ 15,625 total - Award
Stock Option (right to buy)
2025-03-03+62,500→ 62,500 totalExercise: $21.24Exp: 2035-03-03→ Common Stock (62,500 underlying)
Footnotes (3)
- [F1]Grant of restricted stock units ("RSUs") under the Issuer's 2022 Equity Incentive Plan, as amended. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs were granted on March 3, 2025 and will vest in equal installments on each of March 4, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continued service with the company.
- [F2]Includes 15,625 unvested RSUs.
- [F3]The option was granted on March 3, 2025. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 3, 2026 and the remainder are scheduled to vest in equal monthly installments through March 3, 2029.
Documents
Issuer
Schrodinger, Inc.
CIK 0001490978
Entity typeother
Related Parties
1- filerCIK 0001797672
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 5:29 PM ET
- Size
- 7.4 KB